Search results
22 lut 2021 · COV003 is a single-blinded, multi-centre, randomised, controlled Phase III trial assessing the safety, efficacy, and immunogenicity of AstraZeneca’s COVID-19 vaccine in 10,300 participants in Brazil.
Google Scholar provides a simple way to broadly search for scholarly literature. Search across a wide variety of disciplines and sources: articles, theses, books, abstracts and court opinions.
8 gru 2020 · The Oxford/AstraZeneca Covid vaccine is safe and effective, giving good protection, researchers have confirmed in The Lancet, external journal. Most in the study were younger than 55, but the...
Find a clinical trial. This site is part of AstraZeneca`s commitment to provide patients, their relatives, caregivers, doctors, researchers and the public with information about AstraZeneca clinical trials, which includes trials sponsored by a member of the AstraZeneca Group of Companies.
19 maj 2023 · This meta-analysis evaluated the Efficacy and Effectiveness of several COVID-19 vaccines, including AstraZeneca, Pfizer, Moderna, Bharat, and Johnson & Johnson, to better estimate their immunogenicity, benefits, or side effects.
10 gru 2020 · The Oxford/AstraZeneca vaccine this week became the first major COVID vaccine candidate to have efficacy results from phase 3 trials published in a peer-reviewed journal. The vaccine,...
25 mar 2021 · AstraZeneca says it plans to file for emergency-use authorization for the vaccine from the US Food and Drug Administration (FDA), and to submit the analysis of the trial for peer review and...
